Although recurrent infections in Rubinstein–Taybi syndrome (RSTS) are common, and probably multifactorial, immunological abnormalities have not been extensively described with only isolated cases or small case series of immune deficiency and dysregulation having been reported. The objective of this study was to investigate primary immunodeficiency (PID) and immune dysregulation in an international cohort of patients with RSTS. All published cases of RSTS were identified. The corresponding authors and researchers involved in the diagnosis of inborn errors of immunity or genetic syndromes were contacted to obtain up-to-date clinical and immunological information. Ninety-seven RSTS patients were identified. For 45 patients, we retrieved data from the published reports while for 52 patients, a clinical update was provided. Recurrent or severe infections, autoimmune/autoinflammatory complications, and lymphoproliferation were observed in 72.1%, 12.3%, and 8.2% of patients. Syndromic immunodeficiency was diagnosed in 46.4% of individuals. Despite the broad heterogeneity of immunodeficiency disorders, antibody defects were observed in 11.3% of subjects. In particular, these patients presented hypogammaglobulinemia associated with low B cell counts and reduction of switched memory B cell numbers. Immunoglobulin replacement therapy, antibiotic prophylaxis, and immunosuppressive treatment were employed in 16.4%, 8.2%, and 9.8% of patients, respectively. Manifestations of immune dysfunctions, affecting mostly B cells, are more common than previously recognized in patients with RSTS. Full immunological assessment is warranted in these patients, who may require detailed investigation and specific supportive treatment.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Autoimmune lymphoproliferative syndrome
Common variable immunodeficiency
European Society for Immunodeficiencies
Familial Mediterranean fever
Hematopoietic stem cell transplantation
Selective IgA deficiency
Unclassified syndromic immunodeficiency
Negri G, Milani D, Colapietro P, Forzano F, Della Monica M, Rusconi D, et al. Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene. Clin Genet. 2015;87:148–54.
Fergelot P, Van Belzen M, Van Gils J, Afenjar A, Armour CM, Arveiler B, et al. Phenotype and genotype in 52 patients with Rubinstein–Taybi syndrome caused by EP300 mutations. Am J Med Genet Part A. 2016;170A:3069–82.
Stevens CA, Pouncey J, Knowles D. Adults with Rubinstein-Taybi syndrome. Am J Med Genet Part A. 2011;155:1680–4.
Naimi DR, Munoz J, Rubinstein J, Hostoffer RW. Rubinstein-Taybi syndrome: an immune deficiency as a cause for recurrent infections. Allergy Asthma Proc. 2006;27(3):281–4.
Kimura H, Ito Y, Koda Y, Hase Y. Rubinstein-Taybi syndrome with thymic hypoplasia. Am J Med Genet. 1993;46(3):293–6.
Villella A, Bialostocky D, Lori E, Meyerson H, Hostoffer RW. Rubinstein-Taybi syndrome with humoral and cellular defects: a case report. Arch Dis Child. 2000;83(4):360–1.
Freitas NM, Imbronito AV, La Scala CSK, Lotufo RFM, Pustiglioni FE. Periodontal disease in a Rubinstein-Taybi syndrome patient: case report. Int J Paediatr Dent. 2006;16(4):292–6.
Rivas F, Fragoso R, Ramos-Zepeda R, Vaca G, Hernandez A, Gonzalez-Quiroga G, et al. Deficient cell immunity and mild intermittent hyperaminoacidemia in a patient with the Rubinstein-Taybi syndrome. Acta Paediatr. 1980;69(1):123–5.
Hamilton MJ, Newbury-Ecob R, Holder-Espinasse M, Yau S, Lillis S, Hurst JA, et al. Rubinstein-Taybi syndrome type 2: report of nine new cases that extend the phenotypic and genotypic spectrum. Clin Dysmorphol. 2016;25:135–45.
Pasic S. Rubinstein-Taybi syndrome associated with humoral immunodeficiency. J Investig Allergol Clin Immunol. 2015;25(2):137–8.
Rivalta B, Zama D, Pancaldi G, Facchini E, Cantarini ME, Miniaci A, et al. Evans syndrome in childhood: long term follow-up and the evolution in primary immunodeficiency or rheumatological disease. Front Pediatr. 2019;23;7:304.
Saettini F, Moratto D, Grioni A, Maitz S, Iascone M, Rizzari C, et al. A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency. Pediatr Allergy Immunol. 2018;29(7):776–81.
Lougaris V, Facchini E, Baronio M, Lorenzini T, Moratto D, Specchia F, et al. Progressive severe B cell deficiency in pediatric Rubinstein-Taybi syndrome. Clin Immunol. 2016;173:181–3.
Herriot R, Miedzybrodzka Z. Antibody deficiency in Rubinstein-Taybi syndrome. Clin Genet. 2016;89(3):355–8.
Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 Study. J Allergy Clin Immunol. 2003 Nov;112(5):973–80.
Farruggia P, Fioredda F, Puccio G, Porretti L, Lanza T, Ramenghi U, et al. Autoimmune neutropenia of infancy: data from the Italian Neutropenia Registry. Am J Hematol. 2015 Dec;90(12):E221–2.
Romaniouk I, Romero A, Runza P, Nieto C, Mouzo R, Simal F. Management of neuroendocrine tumor in a patient with Rubinstein-Taybi syndrome in chronic hemodialysis. Nefrologia. 2018;38(4):446–8.
Mar N, Digiuseppe JA, Dailey ME. Rubinstein–Taybi syndrome – a window into follicular lymphoma biology. Leuk Lymphoma. 2016;57(12):2908–10.
Kamenarova K, Simeonov E, Tzveova R, Dacheva D, Penkov M, Kremensky I, et al. Identification of a novel de novo mutation of CREBBP in a patient with Rubinstein-Taybi syndrome by targeted next-generation sequencing: a case report. Hum Pathol. 2016;47(1):144–9.
Torres LC, De LL CM, Delboni TP, Okay TS, Carneiro-Sampaio M, Sugayama S. Rubinstein-Taybi syndrome: a female patient with a de novo reciprocal translocation T(2; 16)(Q36.3; P13.3) and dysgranulopoiesis. Clinics. 2010;65(1):107–9.
Torres LC, Sugayama SMM, Arslanian C, Sales MM, Carneiro-Sampaio M. Evaluation of the immune humoral response of Brazilian patients with Rubinstein-Taybi syndrome. Brazilian J Med Biol Res. 2010;43(12):1215–24.
Kosaki R, Kikuchi S, Koinuma G, Higuchi M, Torii C, Kawasaki K, et al. Two patients with Rubinstein-Taybi syndrome and severe pulmonary interstitial involvement. Am J Med Genet A. 2010;152A(7):1844–6.
Kalyoncu U, Tufan A, Karadag O, Kisacik B, Akdogan A, Calguneri M. Rubinstein-Taybi syndrome and familial Mediterranean fever in a single patient: two distinct genetic diseases located on chromosome 16p13.3. J Natl Med Assoc. 2006;98(10):1692–3.
Kim CJ, Nam JH, Chung HY, Kook JH, Kim SY, Woo YJ. Kimura disease in a patient with Rubinstein-Taybi syndrome. Pediatr Int. 2004;46(5):609–11.
Bayle P, Bazex J, Lamant L, Lauque D, Durieu C, Albes B. Multiple perforating and non perforating pilomatricomas in a patient with Churg-Strauss syndrome and Rubinstein-Taybi syndrome. J Eur Acad Dermatology Venereol. 2004;18(5):607–10.
Altintas F, Cakmakkaya S. Anesthetic management of a child with Rubinstein-Taybi syndrome. Paediatr Anaesth. 2004;14(7):610–1.
Çaksen H, Bartsch O, Okur M, Temel H, Açikgöz M, Yilmaz C. Rubinstein-Taybi syndrome and CREBBP c.201-202delTA mutation: a case presenting with varicella meningoencephalitis. Genet Couns. 2009;20(3):255–60.
Shashi V, Fryburg JS. Vascular ring leading to tracheoesophageal compression in a patient with Rubinstein-Taybi syndrome. Clin Genet. 1995;48:324–7.
Jonas DM, Heilbron DC, Ablin AR. Rubinstein-Taybi syndrome and acute leukemia. J Pediatr. 1978;92(5):851–2.
Levinson ED, Spencer RP. Bone scan-demonstrated urinary tract abnormalities in a patient with Rubinstein-Taybi syndrome. Clin Nucl Med. 1980;5(10):454–6.
Rohlfing B, Lewis K, Singleton EB. Rubinstein-Taybi syndrome: report of an unusual case. Am J Dis Child. 1971;121(1):71–4.
Sinnette C, Odeku EL. Rubinstein-Taybi syndrome: the first case in an African child and the first case recognized at birth. Clin Pediatr (Phila). 1968;7:488–92.
Berkhout A, Prociv P, Anthony H, Anthony LT, Clare N. Two cases of neuroangiostrongyliasis: a rare disease because rarely considered or rarely diagnosed? J Paediatr Child Health. 2019;55(12):1463–9.
Noble A, Drouin E, Faure C. Eosinophilic esophagitis and gastritis in Rubinstein-Taybi syndrome. J Pediatr Gastroenterol Nutr. 2007;44(4):498–500.
Shaheed MM, Khamaheh R, Rifai SZ, Abomelha AM. Rubinstein Taybi syndrome and lymphoblastic leukemia. Saudi Med J. 1999;20(10):800–2.
ESID Registry Working Party. ESID Registry - Working definitions for clinical diagnosis of IEI 2019;1–33. Available from: https://esid.org/content/download/16792/456144/file/ESIDRegistry_ClinicalCriteria.pdf
Pieper K, Rizzi M, Speletas M, Smulski CR, Sic H, Kraus H, et al. A common single nucleotide polymorphism impairs B-cell activating factor receptor’s multimerization, contributing to common variable immunodeficiency. J Allergy Clin Immunol. 2014;133:1222–1225.e10.
Ming J.E., Stiehm E.R. Syndromic immunodeficiencies. In: Rezaei N., Aghamohammadi A., Notarangelo L. (eds) Primary immunodeficiency diseases. 2017; Springer, Berlin, Heidelberg.
Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116(14):e35–40.
Wehr C, Kivioja T, Schmitt C, Ferry B, Witte T, Eren E, et al. The EUROclass Trial: defining subgroups in common variable immunodeficiency. Blood. 2008;111(1):77–85.
Posey JE, Harel T, Liu P, Rosenfeld JA, James RA, Coban Akdemir ZH, et al. Resolution of disease phenotypes resulting from multilocus genomic variation. N Engl J Med. 2017;376(1):21–31.
Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017 Jan;139(1):232–45.
Notarangelo LD. PIDs and cancer: an evolving story. Blood. 2010;116(8):1189–90.
The study conformed to the Declaration of Helsinki and was approved by the institutional review boards/ethic committee of Comitato Etico Brianza (Monza, Italy; PID-GENMET).
Conflict of Interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
About this article
Cite this article
Saettini, F., Herriot, R., Prada, E. et al. Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients. J Clin Immunol 40, 851–860 (2020). https://doi.org/10.1007/s10875-020-00808-4
- Rubinstein–Taybi syndrome
- antibody deficiency
- syndromic immunodeficiency
- humoral defects
- B cells